Alexithymia in patients with substance use disorders and its relationship with psychiatric comorbidities and health-related quality of life

Autor: Raul F. Palma-Álvarez, Elena Ros-Cucurull, Constanza Daigre, Marta Perea-Ortueta, Pedro Serrano-Pérez, Nieves Martínez-Luna, Anna Salas-Martínez, María Robles-Martínez, Josep A. Ramos-Quiroga, Carlos Roncero, Lara Grau-López
Přispěvatelé: Institut Català de la Salut, [Palma-Álvarez RF, Ros-Cucurull E, Daigre C, Ramos-Quiroga JA, Grau-López L] Servei de Psiquiatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Psiquiatria i Medicina Legal, Universitat Autònoma de Barcelona, Bellaterra, Spain. Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain. [Perea-Ortueta M] Servei de Psiquiatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Serrano-Pérez P] Servei de Psiquiatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Psiquiatria i Medicina Legal, Universitat Autònoma de Barcelona, Bellaterra, Spain. Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Martínez-Luna N, Salas-Martínez A] Servei de Psiquiatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Alexithymia
medicine.medical_specialty
Impulsivity
Multivariate analysis
lcsh:RC435-571
Health-related quality of life
conducta y mecanismos de la conducta::conducta::síntomas conductuales::síntomas afectivos [PSIQUIATRÍA Y PSICOLOGÍA]
trastornos inducidos químicamente::trastornos relacionados con sustancias [ENFERMEDADES]
Anxiety
Substance use disorder
behavioral disciplines and activities
Toronto Alexithymia Scale
Otros calificadores::Otros calificadores::/complicaciones [Otros calificadores]
Quality of life
lcsh:Psychiatry
Alexitímia
mental disorders
Medicine
Psychiatry
Depression (differential diagnoses)
Original Research
medicine.diagnostic_test
Behavior and Behavior Mechanisms::Behavior::Behavioral Symptoms::Affective Symptoms [PSYCHIATRY AND PSYCHOLOGY]
business.industry
Depression
medicine.disease
humanities
Substance abuse
Psychiatry and Mental health
Chemically-Induced Disorders::Substance-Related Disorders [DISEASES]
medicine.symptom
business
Diagnòstic dual
Other subheadings::Other subheadings::/complications [Other subheadings]
Zdroj: Frontiers in Psychiatry
Scientia
Frontiers in Psychiatry, Vol 12 (2021)
Popis: Alexitimia; Qualitat de vida relacionada amb la salut; Trastorn per consum de substàncies Alexitimia; Calidad de vida relacionada con la salud; Trastorno por uso de sustancias Alexithymia; Health-related quality of life; Substance use disorder Background: Alexithymia frequently correlates with several psychiatric disorders, including substance use disorder (SUD). However, most studies reporting the associations between alexithymia and psychiatric disorders have been performed in populations without SUD. This research, therefore, evaluates alexithymia in Spanish patients with SUD and the relationship among alexithymia, psychiatric comorbidities, psychological symptoms/traits, SUD variables, and health-related quality of life (HRQoL). Methodology: A cross-sectional study was conducted with 126 Spanish outpatients with SUD (75.4% males; mean age 43.72 ± 14.61 years), correlating their alexithymia levels (using the Toronto Alexithymia Scale 20 [TAS-20]) to their psychiatric comorbidities, psychological symptoms/traits, SUD variables, and HRQoL. Results: Alexithymia was significantly higher in patients who had cannabis use disorder. Higher alexithymia scores were also related to higher levels of depression, anxiety, impulsivity, and lower HRQoL. After multivariate analysis, trait anxiety, impulsivity, and the physical component summary of the HRQoL were found to be independently related to alexithymia. Conclusions: SUD patients with higher alexithymia levels have more frequently psychiatric comorbidities, present specific psychological features, and have worse HRQoL. Hence, it is important to evaluate these factors and offer more accurate psychotherapeutic approaches for this patient population.
Databáze: OpenAIRE